These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21184732)

  • 1. WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.
    Zeilstra J; Joosten SP; Wensveen FM; Dessing MC; Schütze DM; Eldering E; Spaargaren M; Pals ST
    Biochem Biophys Res Commun; 2011 Mar; 406(1):1-6. PubMed ID: 21184732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium.
    Kim BM; Mao J; Taketo MM; Shivdasani RA
    Gastroenterology; 2007 Aug; 133(2):529-38. PubMed ID: 17681174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
    Souazé F; Viardot-Foucault V; Roullet N; Toy-Miou-Leong M; Gompel A; Bruyneel E; Comperat E; Faux MC; Mareel M; Rostène W; Fléjou JF; Gespach C; Forgez P
    Carcinogenesis; 2006 Apr; 27(4):708-16. PubMed ID: 16299383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intestinal Wnt/TCF Signature.
    Van der Flier LG; Sabates-Bellver J; Oving I; Haegebarth A; De Palo M; Anti M; Van Gijn ME; Suijkerbuijk S; Van de Wetering M; Marra G; Clevers H
    Gastroenterology; 2007 Feb; 132(2):628-32. PubMed ID: 17320548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
    Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial.
    Campbell KL; McTiernan A; Li SS; Sorensen BE; Yasui Y; Lampe JW; King IB; Ulrich CM; Rudolph RE; Irwin ML; Surawicz C; Ayub K; Potter JD; Lampe PD
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1767-74. PubMed ID: 17855695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.
    Fevr T; Robine S; Louvard D; Huelsken J
    Mol Cell Biol; 2007 Nov; 27(21):7551-9. PubMed ID: 17785439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer.
    Boon EM; van der Neut R; van de Wetering M; Clevers H; Pals ST
    Cancer Res; 2002 Sep; 62(18):5126-8. PubMed ID: 12234972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients.
    D'Orazio D; Muller PY; Heinimann K; Albrecht C; Bendik I; Herzog U; Tondelli P; Bauerfeind P; Müller H; Dobbie Z
    Anticancer Res; 2002; 22(6A):3409-14. PubMed ID: 12530096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the IFITM family as a new molecular marker in human colorectal tumors.
    Andreu P; Colnot S; Godard C; Laurent-Puig P; Lamarque D; Kahn A; Perret C; Romagnolo B
    Cancer Res; 2006 Feb; 66(4):1949-55. PubMed ID: 16488993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.